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Irritable Bowel Syndrome Helped by Montelukast
To the Editor:
During my pulmonology practice, I encountered a patient who had asthma and nontropical sprue. I prescribed treatment with montelukast for this patient. To my surprise, the patient called me 1 week later to report that her sprue was completely better and that, 1 week after stopping her special gluten-free diet while remaining on montelukast, she was diarrhea free for the first time in 30 years! Her asthma also improved markedly. Taking my observation one step further, I initiated montelukast in another patient with sprue and with COPD without bronchospasm. To my amazement, her sprue also improved markedly, such that she was without diarrhea for the first time in 25 years and also on a normal diet.
Montelukast is an active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene receptor. 1 This may certainly explain the very positive effects of montelukast on patients who have sprue. 2, 3 It is also important to note that, in a recent study, 4 20% of patients labeled with irritable bowel syndrome really had an incomplete case of sprue. I believe that many of these patients may also benefit from treatment with montelukast.
William H. Fee, MD Chest Medicine Associates
Franklin, PA 
Pulmonary Involvement in Hepatitis B-Related Polyarteritis Nodosa
We read with interest the report by Guo et al (July 2001) 1 of a patient with hepatitis B-related polyarteritis nodosa (PAN) complicated by pulmonary hemorrhage. Pulmonary involvement, which is rare in patients with PAN, seems to be more frequent in patients with hepatitis B-related PAN, and endothelial cell damage by immune complex deposition could play a role. 
